Comparison between deferoxamine and deferiprone (L1) in iron‐loaded thalassemia patients

Abstract

L1 had comparable efficacy as deferoxamine with minimal side effects and better compliance. Provided long term side effects are not encountered, L1 seems to be a valuable alternative iron chelator for patients unable or unwilling to use deferoxamine effectively.